AVLSA

Atlas Venture Life Science Advisors Portfolio holdings

AUM $790M
1-Year Est. Return 223.66%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+223.66%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$790M
AUM Growth
-$75.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
8
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

1
+$59.8M
2
+$6.48M
3
+$4.7M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KYMR icon
1
Kymera Therapeutics
KYMR
$6.7B
$381M 48.26%
4,578,008
-81,866
DYN icon
2
Dyne Therapeutics
DYN
$3.2B
$166M 20.95%
9,130,465
SION
3
Sionna Therapeutics
SION
$1.93B
$120M 15.2%
2,995,602
IRON icon
4
Disc Medicine
IRON
$2.66B
$96.8M 12.25%
1,513,875
QTTB icon
5
Q32 Bio
QTTB
$187M
$13.4M 1.7%
2,092,106
KRRO icon
6
Korro Bio
KRRO
$193M
$12.9M 1.63%
1,137,149
DAWN
7
DELISTED
Day One Biopharmaceuticals
DAWN
– –
-6,412,560
GBIO
8
DELISTED
Generation Bio
GBIO
– –
-827,946